Stay updated on ATA188 in Progressive MS Clinical Trial
Sign up to get notified when there's something new on the ATA188 in Progressive MS Clinical Trial page.
Latest updates to the ATA188 in Progressive MS Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded a Locations section listing multiple US states and international regions (CA, CO, FL, IN, KS, LA, MA, MO, NY, NC, PA, SC, TN, TX, VA, WA, WI; New South Wales, Queensland, British Columbia, Ontario, Quebec) and a Revision: v3.3.3; removed the prior California Locations, Colorado Locations, etc., and the HHS Vulnerability Disclosure.SummaryDifference2%
- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe additions and deletions are minor editorial changes to the Publications section and the page revision version, affecting wording rather than study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check48 days agoChange DetectedThe page no longer displays a government funding and operating status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check69 days agoChange DetectedNo core content changes were observed; the page shows only minor formatting differences — To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check91 days agoChange DetectedAdded a prominent operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).SummaryDifference3%
- Check98 days agoChange DetectedAdds version v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) plus an older version tag (v3.0.2) indicating a content restructuring.SummaryDifference0.3%
Stay in the know with updates to ATA188 in Progressive MS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ATA188 in Progressive MS Clinical Trial page.